Big Pharma

Got a patent, now where to validate?

For smaller companies and universities, deciding where to validate a pharma patent can be difficult. Sarah Kostiuk-Smith of Mewburn Ellis looks at the options within the European Patent Convention countries.

• Patent filing strategies for pharma startups 16-03-2021
• The importance of Minerva Surgical v Hologic 02-02-2021
• What 2020 means for the life sciences 15-12-2020
• Pricing, patents and the PMPRB in Canada 14-12-2020
• The doctrine of equivalents in the medtech arena 18-11-2020

More big pharma features